VEON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient buyer. The broader trend is constructive (bullish moving averages), but momentum is not accelerating (MACD histogram positive but contracting) and price is sitting right on/just below the pivot (~54.71) after a -1.94% close. With no Intellectia buy signals today and the pattern-based outlook skewing slightly negative for the next week, the risk/reward for an immediate entry isn’t attractive. I would only turn bullish for an immediate buy if VEON reclaims and holds above ~55.98 (R1) with strength; otherwise the more favorable entry is closer to support around ~53.45 (S1).
Trend & momentum: Bullish structure with SMA_5 > SMA_20 > SMA_200, indicating an uptrend bias. However, MACD histogram is above zero (0.0443) but positively contracting, suggesting upside momentum is fading rather than building. RSI_6 at 54.8 is neutral (no oversold bounce signal).
Key levels: Pivot 54.711 is the near-term line in the sand; price (54.67) is slightly below it, implying weak near-term control by buyers. Upside resistance at 55.975 (R1) then 56.756 (R2). Downside supports at 53.446 (S1) then 52.665 (S2).
Intellectia Proprietary Trading Signals
and stated $1B Ukraine investment plan (2023–
may be viewed as growth/visibility catalysts depending on deal reception.
if buyers don’t step in.
Latest quarter: 2025/Q3. Revenue grew to ~1.115B (+7.52% YoY) and gross margin improved to ~69.78% (+1.63% YoY), showing top-line resilience and strong gross profitability. However, net income fell to about -131M (-162.68% YoY) and EPS to -0.08 (-166.67% YoY), indicating worsening bottom-line performance (higher costs/other charges) despite revenue growth.
No analyst rating or price target change data was provided, so a current Wall Street consensus trend (upgrades/downgrades/target revisions) cannot be assessed from the dataset. Based on the information available: pros would center on revenue growth, strong gross margin, and operational modernization; cons would center on the expanding net loss and near-term deal/overhang uncertainty.
